In colorectal cancers with low mutational burden, which are resistant to immunotherapy, depletion of METTL3 and METTL14 increases the expression of CD8+ T cells and the secretion of IFN-γ via the m6A reader YTHDF2 (Wang et al., 2020b). This evidence concerns the gene METTL3 and colorectal cancer.